LCMS
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.
Pořadatel
Agilent Technologies
Agilent Technologies
Analytičtí vědci a kliničtí výzkumníci po celém světě spoléhají na Agilent a na to, že jim pomůže splnit i ty nejsložitější požadavky v laboratoři. Naše přístroje, software, služby a spotřební materiál řeší celou škálu potřeb ve Vaší laboratoři.
Tagy
LC/MS
Logo of LinkedIn

Advance Your Peptide Product Commercialization: Quality and Characterization Considerations

ZÁZNAM | Proběhlo St, 17.7.2024
Zapojte se do série webinářů o celém hodnotovém řetězci terapeutických peptidů.
Přejít na webinář
Agilent: Advance Your Peptide Product Commercialization: Quality and Characterization Considerations

Agilent: Advance Your Peptide Product Commercialization: Quality and Characterization Considerations

Join us for thought provoking webinar series on the entire value chain of therapeutic peptides.

Register now and get an opportunity to learn about:

  • Challenges in analytical test methods
  • Selection of analytical techniques and samples
  • Quality considerations for therapeutic peptide analysis
  • USP quality standards for synthetic peptides and its impurities
  • Sequence identification and confirmation
  • LC/MS based characterization workflow
Analytical Similarity Study in Generic Synthetic Peptide Drug Product: Navigating Standards and Techniques.
  • Dr. Rakesh Shekhawat
  • Dr. Manoj Kumar Metta
Peptide Characterization Using Agilent workflows.
  • Dr. Ashish Pargaonkar

Presenter: Dr. Rakesh Shekhawat (Founder/Owner, Proantek Research Labs Pvt. Ltd)

Dr. Rakesh Shekhawat is a distinguished scientist with over 20 years of industrial research experience in the fields of synthetic peptides, biosimilars, and oligonucleotide characterization. Holding a Ph.D. in analytical chemistry, Dr. Shekhawat has led analytical research teams at prominent companies such as Intas and USV, contributed significantly to securing various regulatory approvals for biosimilars and synthetic peptides. Recently, he founded Proantek Research Labs Pvt. Ltd., a company dedicated to the advanced characterization of biosimilars, synthetic peptides, and oligonucleotides.

Presenter: Dr. Manoj Kumar Metta (Team Lead, Senior Scientist II Global Biologics, United States Pharmacopeia (USP))

Dr. Manoj Metta is a renowned Biological Scientist with 21 years of experience in Biologics Quality assessment, and Regulatory sciences. He has rich hands-on experience in commercial development of protein, and peptide biopharmaceutical products with emphasis on developing analytical control strategies, physicochemical and functional characterization, analytical method development/validations and CMC review to support product licensure in global markets.

Dr. Manoj brings a wealth of experience and expertise to his role at the US Pharmacopeia (USP), where he has served for over 12 years in various scientific capacities. His contributions span across multiple areas, including the development of Monographs, Reference standards and General chapters in therapeutic proteins, monoclonal antibodies, synthetic peptides, and oligonucleotides. Dr. Manoj is a frequent speaker at national and international biopharmaceutical and regulatory scientific events.

Academically, he received Ph.D. degree in Biotechnology from Gandhi Institute of Technology and Management, on “Development of novel mammalian expression systems by using polyomaviral elements in CHO cell line” for monoclonal antibody production”.

Presenter: Dr. Ashish Pargaonkar (Biopharma Workflow Commercialization Lead, Agilent Technologies)

Dr. Ashish Pargaonkar is a Lead for Biopharma Workflow Commercialization team for India and also Manager for Centre of Excellences at Bangalore. A Microbiologist by education with a Ph.D, he holds more than 20 years of experience for Biopharma market applications on Hi Resolution Mass Spectrometry.

He has a long record of successful demonstrations and customer engagements on workflows for CQA’s, Intact mass, peptide mapping, HCP and Glycans using Agilent state-of-the art solutions. He has authored ASMS posters on media components and therapeutic peptides. Dr. Ashish has been invited speaker at several conferences and workshops at Biosimilar Congress, ADC 2018, IIT (Mumbai, Delhi), ICT (Mumbai), PSI events.

Agilent Technologies
Logo of LinkedIn
 

Mohlo by Vás zajímat

Improved LC/MS Performance to Determine Polar Nitrosamines Using the Agilent 1260 Infinity II Hybrid Multisampler

Aplikace
| 2024 | Agilent Technologies
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza

SQ Detector 2

Brožury a specifikace
| 2024 | Waters
Instrumentace
LC/MS, LC/SQ
Výrobce
Waters
Zaměření
Ostatní

Halogens and sulfur in solid samples according to EN 17813

Aplikace
| 2024 | Metrohm
Instrumentace
Iontová chromatografie
Výrobce
Metrohm
Zaměření
Životní prostředí

Determination of carbohydrates in peanuts by HPAE-PAD

Aplikace
| 2024 | Thermo Fisher Scientific
Instrumentace
Iontová chromatografie
Výrobce
Thermo Fisher Scientific
Zaměření
Potraviny a zemědělství

Targeted PFAS Analysis in Industrial Wastewater Using the Agilent 6475 Triple Quadrupole LC/MS System

Aplikace
| 2024 | Agilent Technologies
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Agilent Technologies
Zaměření
Životní prostředí
Další projekty
GCMS
ICPMS
Sledujte nás
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.